PRESS RELEASE published on 10/09/2024 at 17:45, 1 year 4 months ago VALBIOTIS : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Septembre 2024 VALBIOTIS communique sur le nombre de droits de vote et d'actions en septembre 2024. Entreprise française spécialisée en compléments alimentaires pour la santé cardiaque Droits De Vote Actions Valbiotis Compléments Alimentaires Santé Cardiaque
BRIEF published on 09/12/2024 at 17:50, 1 year 5 months ago VALBIOTIS : Information mensuelle sur les droits de vote et actions en août 2024 Droits De Vote Capital Social Actions Euronext Growth Valbiotis
BRIEF published on 09/12/2024 at 17:50, 1 year 5 months ago VALBIOTIS: Monthly information on voting rights and shares in August 2024 Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF published on 09/12/2024 at 17:50, 1 year 5 months ago Valbiotis : Information Mensuelle sur les Droits de Vote et Actions - Août 2024 Droits De Vote Euronext Actions Transparence Valbiotis
BRIEF published on 09/12/2024 at 17:50, 1 year 5 months ago Valbiotis: Monthly Information on Voting Rights and Shares - August 2024 Voting Rights Euronext Actions Transparency Valbiotis
PRESS RELEASE published on 09/12/2024 at 17:45, 1 year 5 months ago VALBIOTIS : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Août 2024 Valbiotis communique sur le nombre total d'actions et de droits de vote, conformément à l'article 223-16 du Règlement Général de l'Autorité des Marchés Financiers. L'entreprise est spécialisée dans les compléments alimentaires pour la prévention des maladies cardiovasculaires Droits De Vote Actions Valbiotis Compléments Alimentaires Marchés Financiers
PRESS RELEASE published on 09/12/2024 at 17:45, 1 year 5 months ago VALBIOTIS : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Août 2024 VALBIOTIS informe mensuellement du total de droits de vote et d'actions en août 2024, conformément aux obligations règlementaires. L'entreprise se concentre sur des compléments alimentaires pour prévenir les troubles métaboliques Droits De Vote Actions Valbiotis Compléments Alimentaires Troubles Métaboliques
BRIEF published on 09/05/2024 at 17:45, 1 year 5 months ago Valbiotis to Present at 2024 EASD Congress Valbiotis TOTUM•63 Prediabetes Type 2 Diabetes EASD 2024
BRIEF published on 09/05/2024 at 17:45, 1 year 5 months ago Valbiotis présentera ses produits au congrès EASD 2024 Valbiotis TOTUM•63 Diabète De Type 2 EASD 2024 Prédiabète
PRESS RELEASE published on 09/05/2024 at 17:40, 1 year 5 months ago VALBIOTIS : Oral presentation at the 2024 EASD congress Valbiotis selected to present clinical results from TOTUM 63 Phase II/III clinical study in prediabetes and type 2 diabetes at 2024 EASD congress. Innovative non-drug solution against type 2 diabetes epidemic Valbiotis Prediabetes TOTUM 63 Clinical Results Type 2 Diabetes
Published on 02/14/2026 at 01:00, 10 hours 10 minutes ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 12 hours 55 minutes ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 17 hours 25 minutes ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 20 hours 35 minutes ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 06:05, 5 hours 5 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 15 hours 50 minutes ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 16 hours 9 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 16 hours 50 minutes ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:07, 17 hours 2 minutes ago EQS-Adhoc: Delticom AG: Based on preliminary, unaudited figures for the FY 2025, full-year revenues are below the forecast, while operating EBITDA is expected to be at the upper end of the forecasted range
Published on 02/13/2026 at 18:05, 17 hours 5 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 17 hours 5 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 17 hours 20 minutes ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 17 hours 20 minutes ago Nombre total d'actions et droits de vote - janvier 2026